Results for U.S. Food and Drug Administration

Share:
1 - 10 of 93
Ronald S. Litman, DO
Ronald S. Litman

Dr. Litman is a crusader for safer medication practices, and his major research interest is on the effects of sedative and anesthetic agents on upper airway patency.

E-mail:
litmanr [at] chop.edu
Robert J. Levy, MD
Robert J. Levy Headshot

Dr. Levy is the director of Cardiology Research, and also serves as program director of the Cardiology National Heart, Lung, and Blood Institute (NHLBI) Research Training Grant. His research interests are the pathophysiology of biomaterials used in medicine, basic mechanisms and novel therapies for heart valve disease, arterial angioplasty, local drug delivery, and nanomedicine. He also has experience over three decades in medical device development.

E-mail:
levyr [at] chop.edu
Dah-Jyuu Wang, PhD
Dah-Jyuu Wang

Dr. Wang works on biomarker identification using multiparametric magnetic resonance imaging and homo- and hetero-nuclear spectroscopy techniques for pediatric disease research including  tumors, iron overload, cystic fibrosis, muscular dystrophy, autism, mitochondrial, Gaucher’s, and Canavan’s diseases.

E-mail:
wangd [at] chop.edu
Di Shu, PhD
Di Shu, PhD

Dr. Shu's research focuses on developing and applying suitable statistical methods for assessing comparative safety and effectiveness of medical products.

E-mail:
shud [at] chop.edu

In the News: Top Pediatrics Program for Medical Schools, First-of-Its-Kind Gene Therapy Trial, Novel Computational Tool

Published on
May 26, 2023
in Cornerstone Blog
In the News: Top Pediatrics Program for Medical Schools, Rare Disease Research, Novel Tool
In this week’s news roundup, CHOP’s Department of Pediatrics ranked No 1. in U.S. News & World Report’s ‘Best Pediatrics Programs’ for medical schools.

CHOP Research Paved Way for First FDA-approved Treatment for Friedreich’s Ataxia

Published on
May 19, 2023
in Cornerstone Blog
CHOP Research Paved Way for First Approved Drug for FA
CHOP research paved the way for the first treatment for Friedreich’s ataxia (FA), an inherited neurodegenerative disease.

ASCGT 26th Annual Meeting Well-Attended by CHOP Scientists

Published on
May 18, 2023
in Cornerstone Blog
ASCGT 26th Annual Meeting Well-Attended by CHOP Scientists
Scientists from Children’s Hospital of Philadelphia attend the American Society of Cell & Gene Therapy Annual Meeting to share their expertise through posters, panel discussions, and workshops.

In the News: Big Data Analysis, High-risk Neuroblastoma, D3b Supports Tumor Sample Milestone

Published on
Apr 14, 2023
in Cornerstone Blog
In the News
Learn about a technique to analyze large datasets, preclinical results that show safety and efficacy of a drug that could help children with high-risk neuroblastoma, and a milestone in the CORSICA project that seeks to cure rare sinonasal cancers.

In the News: FDA Approval, Opioid-related Poisoning, Science Slam, PCORI Funding

Published on
Mar 17, 2023
in Cornerstone Blog
In the News: FDA Approval, Opioid-related Poisoning
Learn about a first-of-its-kind FDA approval and a PCORI project that aims to turn evidence-based research into clinical practice more quickly.

Guest Blog: Enhancing Young Learners’ Knowledge of Rare Diseases

Published on
Feb 28, 2023
in Cornerstone Blog
Enhancing Young Learners’ Knowledge of Rare Diseases
Denise Adams, MD, participated in an FDA-hosted panel discussion about improving young medical professionals’ understanding of rare diseases.
1 - 10 of 93